NCT06978023View on ClinicalTrials.gov

Novel Chinese Medicine Formula for Diabetes

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

February 28, 2027

Conditions
Type 2 Diabetes
Interventions
COMBINATION_PRODUCT

JM-LD

Proprietary formula of extracts of Coptidis Rhizoma, Astragali Radix Lonicerae Japonicae Flos (CAL) plus low dose extract of Ophiopogonis Radix

COMBINATION_PRODUCT

JM-HD

Proprietary formula of extracts of Coptidis Rhizoma, Astragali Radix, Lonicerae Japonicae Flos (CAL) plus high dose extract of Ophiopogonis Radix

COMBINATION_PRODUCT

Placebo

Placebo consisting of excipients, coloring and food ingredients to provide a powder mixture of same weight with similar color, texture and odour

Trial Locations (1)

Unknown

Department of Medicine and Therapeutics, The Chinese University of Hong Kong (CUHK), Ward 3M, Diabetes and Endocrine Research Centre, 3/F Day Treatment Block and Children Wards (Old Block), Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER